Medicine and Dentistry
Biological Marker
100%
Pediatrics
92%
Heart Surgery
55%
Pulmonary Hypertension
52%
Persistent Truncus Arteriosus
40%
Brain Injury
39%
Glial Fibrillary Acidic Protein
37%
Extracorporeal Membrane Oxygenation
24%
Hepatoma Derived Growth Factor
24%
Neonate
23%
Injury
23%
Catheterization
17%
Brain Disease
16%
Cardiovascular System
15%
Cardiac Catheterization
15%
Hemodynamic
14%
Cardiopulmonary Bypass
14%
Brain Natriuretic Peptide
13%
Surgery
13%
Disease Severity
13%
Amino Terminal Sequence
13%
Interleukin 6
13%
Heart Disease
12%
Galectin 3
12%
Pediatrics Patient
11%
Coarctation of the Aorta
11%
Magnetic Resonance Imaging
11%
Endostatin
11%
Smooth Muscle Cell
10%
Coarctation of Aorta
10%
Hypoxic-Ischemic Encephalopathy
9%
Induced Hypothermia
9%
Heart Failure
9%
Tau
9%
Acute Kidney Injury
9%
Carcinogenicity
9%
Diagnosis
8%
Sickle-Cell Disease
8%
Polycyclic Aromatic Hydrocarbon
8%
Very Low Birth Weight
8%
Disease
7%
Hypoxia
7%
Metabolite
7%
Traumatic Brain Injury
7%
Right Ventricular Function
6%
Gene Expression
6%
Surgeon
6%
Risk Stratification
6%
Neonatal Intensive Care Unit
6%
Observational Study
6%
Keyphrases
Pulmonary Arterial Hypertension
28%
Pulmonary Hypertension
25%
Cardiac Surgery
21%
Pediatric Cardiac Surgery
18%
Interleukin-6
18%
Glial Fibrillary Acidic Protein
18%
Readmission
16%
Neonate
15%
Disease Severity
15%
Pediatric Patients
14%
Hepatocyte Growth Factor
13%
Growth Factor Binding
13%
Binding Protein
13%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
13%
Insulin-like
13%
Brain Injury
12%
Brain Injury Biomarker
12%
Congenital Heart Disease
12%
Hypoxic-ischemic Encephalopathy
12%
Endostatin
11%
Galectin-3 (Gal-3)
10%
30-day Readmission
10%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
10%
Gene Expression
10%
Pediatric Hypertension
9%
Cardiac Biomarkers
9%
Therapeutic Hypothermia
9%
Magnetic Resonance Imaging
8%
Novel Biomarkers
8%
Clinical Outcomes
8%
Clinical Model
8%
Disease Survival
8%
MRNA Level
8%
Operative
8%
Blood Biomarkers
8%
Angiotensin II Type 1 Receptor (AT1R)
8%
Neurodevelopmental Outcome
8%
Neurogranin
8%
Renin
8%
Hypertension Disease
8%
Congenital Heart Surgery
7%
Confidence Interval
7%
Sickle Cell Disease
7%
Interleukin-10
7%
Vascular Endothelial Growth Factor
7%
Neurological Injury
7%
Brain-derived Neurotrophic Factor
7%
Society of Thoracic Surgeons
7%
Soluble Suppression of Tumorigenicity 2 (sST2)
6%
Neonatal Encephalopathy
6%
